Data / Drug companies / Guangzhou Meixi Biotechnology Co., Ltd.
Guangzhou Meixi Biotechnology Co., Ltd.: 20 products in the FDA NDC directory, labeler code 84167
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guangzhou Meixi Biotechnology Co., Ltd. (labeler code 84167) lists 20 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 20 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 6, 2026.
The request: Watch Guangzhou Meixi Biotechnology Co., Ltd. (FDA labeler code 84167): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84167
- Products in commercial distribution
- 20
- Packages
- 20
- Finished drugs by generic name
- 14
- Prescription products
- 0
- Over the counter products
- 20
- Flagged as original packager
- 18 of 18 products that carry the flag
- Started marketing in the last 12 months
- 18
- Earliest marketing start
- October 30, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 20 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 20 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Colloidal sulfur | 3 | 1 |
| Nailtific daytime treatment antifungal pen refill | 1 | 1 |
| Apuree pro 1% clotrimazole antifungal cream | 1 | 1 |
| Apuree maximum strength jock itch antifungal | 1 | 1 |
| Tolnaftate | 1 | 99 |
| Apuree pure nailtific extra-strength fungal nail patches | 1 | 1 |
| Apuree nailtific extra-max strength antigungal | 1 | 1 |
| Apuree maximum strength athletes foot antifungal | 1 | 1 |
| Sunscreen spf 50 | 1 | 6 |
| Apuree maximum strength ringworm antifungal | 1 | 1 |
| Apuree pro nailtific maximum strength antifungal patches | 1 | 1 |
| Apuree nailtific maximum strength antifungal patches pro | 1 | 1 |
| Apuree nailtific extra-max strength daytime antigungal | 1 | 1 |
| Apuree nailtific extra-max strength nighttime antifungal | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 9 | 45% |
| Liquid | 7 | 35% |
| Patch | 3 | 15% |
| Aerosol, spray | 1 | 5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Azole Antifungal | 4 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Clopoat CLOPOAT ACNE-CLEARING SPOT | 84167-106 | Cream | Over the counter monograph drugs | October 6, 2026 |
| APUREE PRO 1% Clotrimazole Antifungal Cream | 84167-930 | Cream | Over the counter monograph drugs | September 30, 2026 |
| Mzank sunscreen daily ultimate protection spf50 | 84167-828 | Cream | Over the counter monograph drugs | August 28, 2026 |
| APUREE Maximum Strength Jock Itch Antifungal | 84167-177 | Cream | Over the counter monograph drugs | August 17, 2026 |
| APUREE Maximum Strength Ringworm Antifungal | 84167-175 | Cream | Over the counter monograph drugs | August 17, 2026 |
| APUREE Maximum Strength Athletes Foot Antifungal | 84167-170 | Cream | Over the counter monograph drugs | August 17, 2026 |
| APUREE Prorevive Maximum Strength Antifungal | 84167-192 | Cream | Over the counter monograph drugs | August 8, 2026 |
| Clopoat CLOPOAT ACNE-CLEARING SPOT | 84167-837 | Cream | Over the counter monograph drugs | June 15, 2026 |
| APUREE Pro Nailtific Maximum Strength Dual-Action Antifungal Pen | 84167-364 | Liquid | Over the counter monograph drugs | May 18, 2026 |
| APUREE PRO Nailtific Maximum Strength Antifungal Patches | 84167-335 | Patch | Over the counter monograph drugs | May 18, 2026 |
| APUREE Nailtific Maximum Strength Antifungal Patches PRO | 84167-416 | Patch | Over the counter monograph drugs | May 11, 2026 |
| APUREE Nailtific Maximum Strength Dual-Action Antifungal Pen Pro | 84167-411 | Liquid | Over the counter monograph drugs | May 11, 2026 |
| APUREE Nailtific Extra-Max Strength Nighttime Antifungal | 84167-479 | Liquid | Over the counter monograph drugs | March 30, 2026 |
| APUREE Nailtific Extra-Max Strength Daytime Antigungal | 84167-423 | Liquid | Over the counter monograph drugs | March 30, 2026 |
| APUREE Nailtific Extra-Max Strength Antigungal | 84167-662 | Liquid | Over the counter monograph drugs | February 9, 2026 |
| Ganrek SUNSCREEN SPRAYER Broad Spectrum SPF 50 | 84167-424 | Aerosol, spray | Over the counter monograph drugs | February 7, 2026 |
| Koneuk sunscreen spf50 | 84167-323 | Cream | Over the counter monograph drugs | January 21, 2026 |
| APUREE Pure Nailtific Extra-Strength Fungal Nail Patches | 84167-332 | Patch | Over the counter monograph drugs | November 24, 2025 |
| Nailtific Nighttime Antifungal Renewal Pen Refill | 84167-023 | Liquid | Over the counter monograph drugs | October 31, 2025 |
| Nailtific Daytime Treatment Antifungal Pen Refill | 84167-012 | Liquid | Over the counter monograph drugs | October 30, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.